[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100625957":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":22,"responsibleParty":36,"collaborators":7,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":43,"acronym":7,"eligibilityCriteria":44,"healthyVolunteers":41,"sex":45,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":7,"studyType":51,"phases":7,"briefSummary":52,"conditions":53,"keywords":59,"overallStatus":68,"whyStopped":7,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Fatih Sultan Mehmet Training and Research Hospital","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Zeynep Demir, MD","PRINCIPAL_INVESTIGATOR",[13,18],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Zeynep Demir, medical doctor","CONTACT","+905398399989","zeynepdemir.dr@gmail.com",{"name":19,"role":15,"phone":20,"phoneExt":7,"email":21},"Pınar Akpınar, medical doctor","+905057877442","pinar.pinarakpinar@gmail.com",[23],{"facility":5,"status":7,"city":24,"state":24,"zip":25,"country":26,"countryCode":7,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Istanbul","34752","Turkey (Türkiye)",{"type":28,"coordinates":29},"Point",[30,31],28.94966,41.01384,{"lat":31,"lon":30},[34],{"name":35,"role":15,"phone":20,"phoneExt":7,"email":21},"Pınar Akpınar, MD",{"type":11,"investigatorFullName":37,"investigatorTitle":38,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Zeynep Demir","Medical Doctor","100625957","validity-and-reliability-of-the-hypertonia-assessment-tool-hat-in-stroke-patients-100625957",false,"NCT07429383","Validity and Reliability of the Hypertonia Assessment Tool (HAT) in Stroke Patients","Inclusion Criteria:\n\n* Age 18 years and older\n* Clinically and radiologically confirmed diagnosis of stroke (ischemic or -hemorrhagic)\n* Brunnstrom stage between 2 and 6\n* Presence of post-stroke hypertonia (spasticity, dystonia, or rigidity)\n* Cognitive level sufficient to cooperate with assessments (Mini-Mental State Examination (MMSE) score \\>23 or equivalent clinical evaluation)\n* Provision of written informed consent\n\nExclusion Criteria:\n\n* Age under 18 years\n* Presence of severe accompanying neurodegenerative diseases (e.g., Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis)\n* Presence of primary musculoskeletal disorders affecting motor performance (e.g., rheumatologic diseases, fractures)\n* Brunnstrom stage of 1\n* Severe aphasia, impaired consciousness, or cognitive deficits preventing effective communication and cooperation\n* Any psychiatric disorder that may interfere with study participation","ALL","18 Years","80 Years",{"count":49,"type":50},60,"ESTIMATED","OBSERVATIONAL","In this study, the validity and reliability of the Hypertonia Assessment Tool (HAT), which has previously been validated in the pediatric cerebral palsy (CP) population, will be evaluated in adult individuals who have experienced a stroke. The HAT is a specific clinical instrument designed to differentiate subtypes of hypertonia, including spasticity, dystonia, and rigidity.\n\nAccurate classification of hypertonia subtypes following stroke is crucial for guiding rehabilitation strategies. However, the HAT has not yet been validated in the adult post-stroke population. This study will be conducted at the Physical Medicine and Rehabilitation Clinic of SBU Fatih Sultan Mehmet Training and Research Hospital. The study aims to evaluate the validity and reliability of the HAT for use in adults with stroke.",[54,55,56,57,58],"Stroke","Hypertonia","Dystonia","Rigidity","Hemiplegia",[60,61,62,63,64,65,66,67],"hypertonia","dystonia","rigidity","reliability","validity","hemiplegia","spasticity","stroke","NOT_YET_RECRUITING","2026-02-20",{"date":71,"type":72},"2026-02-24","ACTUAL",{"date":74,"type":50},"2026-03-01",{"date":76,"type":50},"2026-10-01",{"name":5,"class":6},1]